Does CABOZANTINIB S-MALATE Cause Alopecia? 722 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 722 reports of Alopecia have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 1.8% of all adverse event reports for CABOZANTINIB S-MALATE.
722
Reports of Alopecia with CABOZANTINIB S-MALATE
1.8%
of all CABOZANTINIB S-MALATE reports
10
Deaths
67
Hospitalizations
How Dangerous Is Alopecia From CABOZANTINIB S-MALATE?
Of the 722 reports, 10 (1.4%) resulted in death, 67 (9.3%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Alopecia Listed in the Official Label?
Yes, Alopecia is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Alopecia?
DOCETAXEL (29,347)
METHOTREXATE (14,360)
ADALIMUMAB (13,726)
ETANERCEPT (11,390)
INFLIXIMAB (10,374)
LEFLUNOMIDE (10,267)
RITUXIMAB (10,119)
ABATACEPT (10,043)
TOCILIZUMAB (9,680)
HYDROXYCHLOROQUINE (9,653)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Alopecia Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE